Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment.

Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions: A Health Technology Assessment. — Ontario health technology assessment series 20190417

النشر

Ontario health technology assessment series 20190417

الوصف

1-166 p.

الموضوعات

Cost-Benefit Analysis؛ Diagnostic Tests, Routine؛ Down Syndrome؛ Female؛ Health Care Costs؛ Humans؛ Pregnancy؛ Prenatal Diagnosis